Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Longqi capsule plus spirulina in advanced non-small cell lung cancer
CTR20140011Phase 2Active
- Sponsor
- Nanjing Luye Pharmaceutical
- Start
- May 2014
- Countries
- 1
01
Overview
A Phase 2 trial of Longqi Capsule in non-small cell lung cancer (NSCLC), sponsored by Nanjing Luye Pharmaceutical. Started May 2014; status: active.
02
Drugs
Longqi Capsule
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on CTR20140011.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140011.